AUTHOR=Gao Dongkai , Zhou Zumo , Huang Heqing 

TITLE=miR-30b-3p Inhibits Proliferation and Invasion of Hepatocellular Carcinoma Cells via Suppressing PI3K/Akt Pathway

JOURNAL=Frontiers in Genetics

VOLUME=Volume 10 - 2019

YEAR=2019

URL=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2019.01274

DOI=10.3389/fgene.2019.01274

ISSN=1664-8021

ABSTRACT=Background: miR-30b-3p has been reported to play crucial role in several cancers. However, the biological function of miR-30b-3p in hepatocellular carcinoma (HCC) is still unknown. 
Methods: RT-qPCR was employed to determine the expression of miR-30b-3p in HCC tissues and cells. MTT assay, colony formation assay, cell migration and invasion assay were employed to evaluate the role of miR-30b-3p in HCC cells. Dual-luciferase reporter assay was employed to verify the target of miR-30b-3p. Western blot was employed to determine the expression of key molecular in TRIM27-PI3K/Akt axis.
Results: miR-30b-3p expression was markedly decreased in HCC tissues and cells, and positively correlated with higher overall survival. Moreover, miR-30b-3p overexpression significantly repressed cell viability, proliferation, migration and invasion of HCC cells in vitro. Notably, we demonstrated that miR-30b-3p directly bound to the 3′-untranslated region of tripartite motif containing 27 (TRIM27) mRNA by downregulating the expression of TRIM27, which was demonstrated to be negatively correlated with miR-30b-3p expression. TRIM27 was demonstrated to have an oncogenic role in HCC cells by enhancing cell viability, proliferation, migration and invasion. Finally, the miR-30-3p-TRIM27-PI3K/Akt axis was shown to play a crucial role in HCC cells in vitro. 
Conclusion: Our results indicated that miR-30-3p might act as a new biomarker for the diagnosis and treatment HCC in future.